Advertisement

Apolipoprotein E genotype is associated with serum C-reactive protein but not abdominal aortic aneurysm

      Abstract

      Objective

      Apolipoprotein E (ApoE) genotype has been associated with systemic inflammation and athero-thrombosis however the association with abdominal aortic aneurysm (AAA) has not been previously examined. We assessed the association between ApoE genotype with AAA presence and growth, and serum C-reactive protein (CRP).

      Methods

      Serum concentrations of CRP (in 1358 men) and 6 single nucleotide polymorphisms (SNPs) for ApoE (in 1711 men) were examined in subjects from the Health In Men Study. 640 men with small AAAs were followed by ultrasound surveillance for a mean of 4.1 years.

      Results

      There was no association between ApoE genotype and AAA presence. Men heterozygote for the ApoE p.Arg176Cys polymorphism had slower AAA growth, odds ratio for AAA progression ≥ median 0.41, 95% confidence intervals 0.21–0.80, p = 0.01. Men heterozygote for the ApoE g.50093756A > G polymorphism had slightly more rapid AAA growth, odds ratio for AAA progression ≥ median 1.48, 95% confidence intervals 1.02–2.14, p = 0.04. None of the ApoE SNPs were associated with AAA growth however taking into account multiple testing. Two SNPs in ApoE were associated with serum CRP under a co-dominant model, ApoE p.Cys130Arg (SNP ID rs429358), p = 0.00003 and ApoE g.50114786A > G (SNP ID rs4420638), p = 0.00013. Adjusting for other risk factors plus serum creatinine the ɛ4 allele was associated with lower serum CRP under a dominant model, coefficient 0.089, p = 0.002.

      Conclusion

      We found no consistent association between ApoE genotype and AAA. We confirmed an association between ApoE genotype and serum CRP.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Atherosclerosis
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kockx M.
        • Jessup W.
        • Kritharides L.
        Regulation of endogenous apolipoprotein E secretion by macrophages.
        Arterioscler Thromb Vasc Biol. 2008; 28: 1060-1067
        • Mahley R.W.
        • Rall Jr., S.C.
        Apolipoprotein E far more than a lipid transport protein.
        Annu Rev Genom Hum Genet. 2000; 1: 507-537
        • Klos K.L.
        • Sing C.F.
        • Boerwinkle E.
        • et al.
        Consistent effects of genes involved in reverse cholesterol transport on plasma lipid and apolipoprotein levels in CARDIA participants.
        Arterioscler Thromb Vasc Biol. 2006; 26: 1828-1836
        • Chasman D.I.
        • Kozlowski P.
        • Zee R.Y.
        • Kwiatkowski D.J.
        • Ridker P.M.
        Qualitative and quantitative effects of APOE genetic variation on plasma C-reactive protein. LDL-cholesterol, and apoE protein.
        Genes Immun. 2006; 7: 211-219
        • Eiriksdottir G.
        • Aspelund T.
        • Bjarnadottir K.
        • et al.
        Apolipoprotein E genotype and statins affect CRP levels through independent and different mechanisms: AGES-Reykjavik Study.
        Atherosclerosis. 2006; 186: 222-224
        • Lange L.A.
        • Burdon K.
        • Langefeld C.D.
        • et al.
        Heritability and expression of C-reactive protein in type 2 diabetes in the Diabetes Heart Study.
        Ann Hum Genet. 2006; 70: 717-725
        • Tziakas D.N.
        • Chalikias G.K.
        • Antonoglou C.O.
        • et al.
        Apolipoprotein E genotype and circulating interleukin-10 levels in patients with stable and unstable coronary artery disease.
        J Am Coll Cardiol. 2006; 48: 2471-2481
        • März W.
        • Scharnagl H.
        • Hoffmann M.M.
        • Boehm B.O.
        • Winkelmann B.R.
        The apolipoprotein E polymorphism is associated with circulating C-reactive protein (the Ludwigshafen risk and cardiovascular health study).
        Eur Heart J. 2004; 25: 2109-2119
        • Bennet A.M.
        • Di Angelantonio E.
        • Ye Z.
        • et al.
        Association of apolipoprotein E genotypes with lipid levels and coronary risk.
        JAMA. 2007; 298: 1300-1311
        • Song Y.
        • Stampfer M.J.
        • Liu S.
        Meta-analysis: apolipoprotein E genotypes and risk for coronary heart disease.
        Ann Intern Med. 2004; 141: 137-147
        • Golledge J.
        • Muller J.
        • Daugherty A.
        • Norman P.
        Abdominal aortic aneurysm: pathogenesis and implications for management.
        Arterioscler Thromb Vasc Biol. 2006; 26: 2605-2613
        • Daugherty A.
        • Manning M.W.
        • Cassis L.A.
        Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.
        J Clin Invest. 2000; 105: 1605-1612
        • Gerdes L.U.
        • Lindholt J.S.
        • Vammen S.
        • Henneberg E.W.
        • Fasting H.
        Apolipoprotein E genotype is associated with differential expansion rates of small abdominal aortic aneurysms.
        Br J Surg. 2000; 87: 760-765
        • Gregg R.E.
        • Brewer Jr., H.B.
        The role of apolipoprotein E and lipoprotein receptors in modulating the in vivo metabolism of polipoprotein B-containing lipoproteins in humans.
        Clin Chem. 1988; 34: B28-32
        • Banares V.G.
        • Peterson G.
        • Aguilar D.
        • et al.
        Association between the APOE*4 allele and atherosclerosis is age dependent among Argentine males.
        Hum Biol. 2005; 77: 247-256
        • Jamrozik K.
        • Norman P.E.
        • Spencer C.A.
        • et al.
        Screening for abdominal aortic aneurysm: lessons from a population-based study.
        Med J Aust. 2000; 173: 345-350
        • Norman P.E.
        • Jamrozik K.
        • Lawrence-Brown M.M.
        • et al.
        Impact of screening on mortality from abdominal aortic aneurysm: results of a large, population-based randomised controlled trial.
        BMJ. 2004; 329: 1259-1262
        • Golledge J.
        • Clancy P.
        • Jamrozik K.
        • Norman P.E.
        Obesity, adipokines, and abdominal aortic aneurysm: health in men study.
        Circulation. 2007; 116: 2275-2279
        • Norman P.E.
        • Flicker L.
        • Almeida O.P.
        • et al.
        Cohort Profile: the Health In Men Study (HIMS).
        Int J Epidemiol. 2009; 38: 48-52
        • Norman P.
        • Spencer C.A.
        • Lawrence-Brown M.M.
        • Jamrozik K.
        C-reactive protein levels and the expansion of screen-detected abdominal aortic aneurysms in men.
        Circulation. 2004; 110: 862-866
        • Golledge J.
        • Clancy P.
        • Jones G.T.
        • et al.
        Possible association between genetic polymorphisms in transforming growth factor beta receptors, serum transforming growth factor beta1 concentration and abdominal aortic aneurysm.
        Br J Surg. 2009; 96: 628-632
        • Mazzone T.
        • Reardon C.
        Expression of heterologous human apolipoprotein E by J774 macrophages enhances cholesterol efflux to HDL3.
        J Lipid Res. 1994; 35: 1345-1353
        • Ali K.
        • Middleton M.
        • Pure E.
        • Rader D.J.
        Apolipoprotein E suppresses the type I inflammatory response in vivo.
        Circ Res. 2005; 97: 922-927
        • Dallongeville J.
        • Lussier-Cacan S.
        • Davignon J.
        Modulation of plasma triglyceride levels by apoE phenotype: a meta-analysis.
        J Lipid Res. 1992; 33: 447-454
        • Grönroos P.
        • Raitakari O.T.
        • Kähönen M.
        • et al.
        Association of high sensitive C-reactive protein with apolipoprotein E polymorphism in children and young adults: the Cardiovascular Risk in Young Finns Study.
        Clin Chem Lab Med. 2008; 46: 179-186
        • Ridker P.M.
        • Pare G.
        • Parker A.
        • et al.
        Loci related to metabolic-syndrome pathways including LEPR, HNF1A, IL6R, and GCKR associate with plasma C-reactive protein: the Women's Genome Health Study.
        Am J Hum Genet. 2008; 82: 1185-1192
        • Ortiz M.A.
        • Campana G.L.
        • Woods J.R.
        • et al.
        Continuously-infused human C-reactive protein is neither proatherosclerotic nor proinflammatory in apolipoprotein e-deficient mice.
        Exp Biol Med (Maywood). 2009; 234: 624-631
        • Angelopoulos T.J.
        • Miles M.P.
        • Lowndes J.
        • et al.
        Apolipoprotein E genotype and sex influence C-reactive protein levels regardless of exercise training status.
        Metabolism. 2008; 57: 1204-1210
        • Berrahmoune H.
        • Herbeth B.
        • Siest G.
        • Visvikis-Siest S.
        Heritability of serum hs-CRP concentration and 5-year changes in the Stanislas family study: association with apolipoprotein E alleles.
        Genes Immun. 2007; 8: 352-359
        • Rontu R.
        • Ojala P.
        • Hervonen A.
        • et al.
        Apolipoprotein E genotype is related to plasma levels of C-reactive protein and lipids and to longevity in nonagenarians.
        Clin Endocrinol (Oxf). 2006; 64: 265-270